203 related articles for article (PubMed ID: 18706281)
1. Rosiglitazone and cardiovascular risk.
Kaul S; Diamond GA
Curr Atheroscler Rep; 2008 Oct; 10(5):398-404. PubMed ID: 18706281
[TBL] [Abstract][Full Text] [Related]
2. Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death.
Diamond GA; Bax L; Kaul S
Ann Intern Med; 2007 Oct; 147(8):578-81. PubMed ID: 17679700
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone and cardiovascular risk.
Mannucci E; Monami M; Marchionni N
N Engl J Med; 2007 Aug; 357(9):938; author reply 939-40. PubMed ID: 17806136
[No Abstract] [Full Text] [Related]
4. Rosiglitazone: a thunderstorm from scarce and fragile data.
Mulrow CD; Cornell J; Localio AR
Ann Intern Med; 2007 Oct; 147(8):585-7. PubMed ID: 17938398
[No Abstract] [Full Text] [Related]
5. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
Nissen SE; Wolski K
N Engl J Med; 2007 Jun; 356(24):2457-71. PubMed ID: 17517853
[TBL] [Abstract][Full Text] [Related]
6. Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.
Loke YK; Kwok CS; Singh S
BMJ; 2011 Mar; 342():d1309. PubMed ID: 21415101
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.
Starner CI; Schafer JA; Heaton AH; Gleason PP
J Manag Care Pharm; 2008; 14(6):523-31. PubMed ID: 18693776
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone and cardiovascular risk.
Diamond GA; Kaul S
N Engl J Med; 2007 Aug; 357(9):938-9; author reply 939-40. PubMed ID: 17806135
[No Abstract] [Full Text] [Related]
9. The record on rosiglitazone and the risk of myocardial infarction.
Psaty BM; Furberg CD
N Engl J Med; 2007 Jul; 357(1):67-9. PubMed ID: 17551162
[No Abstract] [Full Text] [Related]
10. [Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect].
Erdmann E; Scherbaum WA
MMW Fortschr Med; 2007 Dec; 149(49-50):49-50. PubMed ID: 18236983
[No Abstract] [Full Text] [Related]
11. Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007.
Boyle P
South Med J; 2007 Nov; 100(11):1063-4. PubMed ID: 17984728
[No Abstract] [Full Text] [Related]
12. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone and cardiovascular risk.
Psaty BM; Furberg CD
N Engl J Med; 2007 Jun; 356(24):2522-4. PubMed ID: 17517854
[No Abstract] [Full Text] [Related]
14. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
Home PD; Pocock SJ; Beck-Nielsen H; Gomis R; Hanefeld M; Jones NP; Komajda M; McMurray JJ;
N Engl J Med; 2007 Jul; 357(1):28-38. PubMed ID: 17551159
[TBL] [Abstract][Full Text] [Related]
16. [Doubts as to the cardiovascular safety of rosiglitazone].
Hoekstra JB; Bossuyt PM; de Vries JH
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1449-50. PubMed ID: 17633972
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone and cardiovascular disease: an epidemiologist's perspective.
McGuire DK
Diab Vasc Dis Res; 2007 Jun; 4(2):77-9. PubMed ID: 17654438
[No Abstract] [Full Text] [Related]
18. Rosiglitazone and cardiovascular disease: a diabetologist's perspective.
Grant PJ
Diab Vasc Dis Res; 2007 Jun; 4(2):75-6. PubMed ID: 17654437
[No Abstract] [Full Text] [Related]
19. [Therapy with glitazones--a risk for cardiovascular disease?].
Rottlaender D; Michels G; Erdmann E; Hoppe UC
Dtsch Med Wochenschr; 2007 Dec; 132(49):2629-32. PubMed ID: 18050028
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone and cardiovascular disease: a cardiologist's perspective.
Marx N
Diab Vasc Dis Res; 2007 Jun; 4(2):80-1. PubMed ID: 17654439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
